Introduction
Endothelial cell senescence plays a role in human aging and agerelated vascular disorders. Senescent endothelial cells are present in human atherosclerotic lesions (Minamino et al., 2002) , where they are likely to promote pathology (Childs et al., 2016; Fyhrquist et al., 2013; Krouwer et al., 2012) . Both transgenic and pharmacological approaches to clear senescent cells have provided preclinical evidence that selective ablation could contribute to the development of new therapeutic approaches to treating cardiovascular disease (Childs et al., 2016; SotoGamez and Demaria, 2017) . However, to date few compounds able to selectively ablate senescent cells (senolytic drugs) are known, and they are not effective in all senescent cell types (Soto-Gamez and Demaria, 2017) .
Why senescent cells accumulate in tissues and organs with age is still a key open question. Accumulation of senescent cells in aged tissues may be driven by several factors including an increased rate of formation of senescent cells, loss of senescence immunosurveillance, bystander effects caused by secretory phenotype on neighbouring cells and upregulation of intrinsic anti-apoptotic factors (van Deursen, 2014) . Since Zn ions are important mediators of apoptotic pathways, and can both enhance or repress functional apoptosis (Garufi et al., 2016; McCabe et al., 1993; Perry et al., 1997; Truong-Tran et al., 2000; Zalewski et al., 1994) , manipulating the exposure of cells to Zn may be an effective strategy to modulate cell senescence or to promote the death of senescent cells. In support of this idea, quercetin, a natural polyphenol and Zn ionophore (Dabbagh-Bazarbachi et al., 2014) , induced selective death of senescent endothelial cells over proliferating cells (Zhu et al., 2015) . Moreover, dysregulated Zn balance has been shown to induce senescence in dermal fibroblasts (Rudolf and Cervinka, 2011) and the Zn ionophore pyrithione was identified as a senescenceinducing compound in a screen of 4160 compounds (Ewald et al., 2009 ). Zn deficiency is considered a risk factor for the development of atherosclerosis (Beattie and Kwun, 2004) , but the cellular and molecular basis of this association has not been investigated in depth. We propose that the influence of Zn on endothelial cell senescence makes an important contribution to this observation. Since impaired Zn homeostasis is a feature of older age, we also propose that altered Zn homeostasis in senescent compared with replicating endothelial cells is an interacting influence. Commensurate with this idea, experiments performed in a vascular smooth muscle cell model suggest that cellular senescence is a Zn-dependent mechanism driven by specific Zn transporters involved in the regulation of intracellular Zn ions (Patrushev et al., 2012) . The complex homeostatic network to which these transporters belong includes members of two families of Zn transporters, which together comprise 24 genes (Cousins et al., 2006; Lichten and Cousins, 2009) , metallothioneins (MTs) (Mocchegiani et al., 2013) , and Zn sensors (ZNF658 and MTF-1) (Choi and Bird, 2014; Ogo et al., 2015) .
The purpose of this study was to investigate: 1) the impact of chronic treatment with a moderate excess of Zn on Zn content and distribution and on replicative potential and senescence in human coronary artery endothelial cells (HCAECs); 2) changes in Zn homeostasis over the lifespan of endothelial cells, using passage number as a surrogate for senescence, using transcriptomic data from two endothelial cell models (HCAECs and Human Umbilical Vein Endothelial Cells-HUVECs); 3) the impact of Zn and passage number on the expression of major players in Zn homeostasis over the culture lifespan of HCAECs; 4) the susceptibility to cell death induced by increasing doses of Zn or of the Zn chelator TPEN at early and later passages of HCAECs.
Material and methods

Cell culture
HCAECs (Human coronary artery endothelial cells) were purchased from Clonetics Corporation (Lonza) and cultured in endothelial basal medium EBM, supplemented with EGM-2/MV SingleQuots with or without addition of 50 μM ZnSO 4 . This concentration has been already defined by others as moderately excessive and does not have a significant effect on the growth or morphology of endothelial cells (Bobilya et al., 2008) . HCAECs were plated at a seeding density of 2500 cells/cm 2 in T 25 flasks and passaged serially. Harvested cells were counted using the Trypan blue viability stain. Population doublings (PD) were calculated using the formula (log 10 UCY − log 10 I) × 3.32 (where UCY is the number of cells at the end of the passage and I is the number of cells initially seeded). Cells were collected for immediate assessment by flow cytometry or for RNA extraction for subsequent analysis of gene expression. Total RNA was extracted from HCAECs using the RNeasy Mini Kit (Qiagen, Hilden, Germany), according to the manufacturer's instructions. RNA concentration and purity were measured using a NanoDrop spectrometer and samples were stored at − 80°C for measurement using RT-PCR.
Senescence biomarkers
HCAECs were grown for subsequent passages until two consecutive population doublings equal to or below 0 were achieved, associated with morphological changes indicating senescence revealed by microscopy and flow cytometry. Cumulative population doubling (CPD) was calculated as the sum of all population doublings (PDs). Senescence associated beta-galactosidase activity (SA-β-gal) was measured by flow cytometry as described previously (Noppe et al., 2009) . As an additional biomarker of senescence, p16 mRNA levels were measured by real-time RT-PCR. Positive staining with propidium iodide was used as the marker of cell viability.
Measurement of labile Zn and metallothionein protein
Labile Zn was measured by flow cytometry using the membrane permeable Zn specific probe Fluozin-3-AM (Haase et al., 2006) . Localization of fluorescence after staining endothelial cells with the membrane permeable Zn probe and Lysotracker red (Thermofischer Scientific) was detected by imaging flow cytometry (Flowsight, Amnis Corporation, Seattle, WA, USA), as described previously for brain endothelial cells (Lopes Pinheiro et al., 2016) . Briefly, cells were acquired on the basis of their area. Analysis was performed with a 488 nm laser line on single cells after compensation. The relative level of co-localization was calculated using the bright detail similarity feature R3 in the Ideas v6.0 software (Amnis-Merck Millipore). This feature corresponds to the logarithmic transformation of Pearson's correlation coefficient of the localized bright spots with a radius of 3 pixels or less within the whole cell area in the two input images. Labile Zn spots marked by Fluozin-3 were calculated using the spot count feature of the Ideas software.
Metallothionein protein expression was measured by flow cytometry following a previously-established protocol (Malavolta et al., 2008; Malavolta et al., 2007; Malavolta et al., 2006 
Quantitative reverse transcription polymerase chain reaction (qRT-PCR)
cDNA synthesis from total RNA was performed using i-Script reverse transcriptase (Biorad, Hercules, CA) according to the manufacturer's guidelines. Messenger RNA for β-actin and GAPDH (glyceraldehyde-3-phosphate dehydrogenase) reference genes and for p16, SLC30A1, SLC39A6, SLC39A1, SLC39A2, SLC39A3, SLC30A5, SLC30A10, CBWD, ZNF658, MT2A, MT1X and MT1F was then measured by real-time PCR on a BioRad iQ5 optical realtime thermal cycler (Biorad, Hercules, CA) using 1 μg of cDNA in a total volume of 25 μl containing iQ SYBR Green Supermix (Biorad, Hercules, CA). Primer sequences and thermal cycling parameters for SLC30A5, SLC30A10, CBWD, and GAPDH were as specified previously (Coneyworth et al., 2012) . The other primers used are listed in Supplementary Table 1. Primer concentrations of 200 nM were used for MT1X, MT2A, SLC30A1, ZNF658, SLC39A3 and SLC309A6 genes; 150 nM for p16 and β-ACTIN, and 300 nM for MT1F and SLC39A2 genes. Assays for each transcript were carried out as duplicates. Fold changes relative to the control condition at the earliest passage were calculated using the ΔΔCt method. β-Actin was used as the reference gene for p16. GAPDH was used as the reference gene for the other mRNAs measured. Data are compared to the control condition at the earliest passage.
Whole genome expression analysis
Data were obtained using the GeneChip 3′ IVT Express kit (Affymetrix, Santa Clara, CA, USA). An integrated meta-analysis of the original *.CEL files was performed using Partek Genomic Suite Software v6.6 (Partek Inc.) and data from 3 replicates each of HuVECs and HCAECs harvested at early and late passages (passages 4 and 18 for HuVECs; passages 6 and 12 for HCAECs). For statistical analysis, we first identified genes significantly (p < 0.05 and FDR < 0.05) upregulated and downregulated in late compared with early-passage cells (both HUVEC and HCAEC) using the ANOVA tool integrated in the Partek Genomic Suite. Those genes in this list known to regulate Zn homeostasis were selected for cluster analysis. We also imported probesets data in SPSS v. 22 (IBM) and performed principal component analysis using all probesets tagged to Zn transporters, MTs and metal transcription factors. Correlation between the functions identified through this analysis and genes believed to promote survival in senescent cells was also determined. Comparison among experimental groups for labile Zn and other data acquired using targeted (as opposed to transcriptome-wide) measurements was performed using a mixed models tool for repeated measures in SPSS v. 22 (IBM). In order to take into account eventual unbalanced data, we set build options with Satterthwaite approximation and used robust estimation to handle violations of model assumption. Post-hoc comparisons were performed by LSD.
Results
Growth and replicative senescence of control and Zn-treated HCAEC cultures
To determine if the presence of Zn (50 μM) in the medium affects the growth, survival and replicative senescence of HCAECs, cells were subjected to serial passage and growth was monitored in Zn-supplemented and control medium by examining replicative capability over the culture lifespan. Regardless of treatment with Zn, cells appeared to undergo growth arrest after passage nine ( Fig. 1 -Panel A and Table 1 ). However, growth arrest in Zn-treated cells was accelerated compared with control cells, suggesting that Zn stimulated transition to senescence. We observed a decline in cell viability in the later passages, which is a usual observation when culturing primary human endothelial cells (Unterluggauer et al., 2003; Wagner et al., 2001) . Notably, cell viability was higher in control cells compared with Zntreated cells after passage 9 (Table 1) . Almost all Zn-treated cells (approximately 90%) had undergone cell death by passage 11, whereas only approximately 40% of control cells had undergone cell death by this point. Measurement of SA-β-gal staining and p16 expression as biomarkers of senescence revealed increases induced by the Zn treatment at late passages ( Fig. 1 -Panels B and C).
Effects of passage number and Zn treatment on Zn content and distribution and on morphology of HCAECs
To determine if Zn-induced senescence is accompanied by changes in labile Zn in endothelial cells, we performed flow cytometric measurements of labile Zn using the probe Fluozin3-AM during serial passage of Zn-treated and control HCAECs. We additionally characterized two distinct sub-populations of cells (Fig. 2) . These two gates represent two populations discriminated by forward and side scatter that have some features, respectively, of replicating and senescent cells. We refer hereafter to the sub-population that features larger cells (revealed by forward scatter) and granularity (revealed by side scatter) as the "Large-HCAEC" (L-HCAEC) sub-population. This sub-population increases as a proportion of the total cell number with increasing CPDs and Zn treatment ( Fig. 2 -Panel C) and in later passages includes more cells that are highly positive for SA-β-gal (Suppl. Fig. 1 ). We refer to the smaller, less granular sub-population of cells that are predominant in rapidly replicating passages as the "non-Large-HCAEC" (nL-HCAEC) sub-population. Representative examples of histograms obtained with Fluozin3 in these 2 gates are shown in Fig. 2 (Panels D and E). The measurement of intracellular labile Zn was performed after estimating minimum and maximum fluorescence with TPEN and pyrithione, respectively (Haase et al., 2006 ).
Zn appears to be positively correlated with CPDs in ungated cells as well as in nL-HCAEC and L-HCAEC sub-populations. (Fig. 3 ). When we grouped cells by CPDs as early (1-6 CPDs), medium (7-11 CPDs) and late (> 11 CPDs), we observed a significant increase in labile Zn in untreated HCAECs at late CPDs compared with the other two groups (Fig. 3 , panels D and E) and this change was accelerated by Zn treatment. Moreover, labile Zn levels were increased in the L-HCAEC compared with nL-HCAEC sub-population at early (p < 0.01), middle (p < 0.01) and late (p < 0.05) CPDs (Fig. 3 , panel E in comparison to Fig. 3, panel D) . Zn treatment significantly increased the levels of labile Zn in both sub-populations. Labile Zn in L-HCAEC was higher than the respective measurement performed in the nL-HCAEC gate. Imaging flow cytometry confirmed the higher Fluozin-3 signal in the senescence-enriched L-HCAEC sub-population at later passages (Suppl. Fig. 2 , Panels a, b and c). Many cells displayed punctuate fluorescent spots, which were at higher numbers in the L-HCAEC subpopulation compared with the nL-HCAEC sub-population (Suppl. Fig. 2 , Panel d) but at lower numbers in the L-HCAEC sub-population at later compared with earlier passages (Suppl. Fig. 2 , Panels d, e, f). Morphological analysis of Fluozin-3 fluorescence revealed that this apparent loss of fluorescent spots at later passages in the L-HCAEC subpopulation was compensated by a diffused fluorescence (Suppl. Fig. 2 Panels g and h). Since an expansion of the lysosomal compartment is a feature of senescent cells, we predicted that the increased labile Zn at later passage numbers was located in this compartment. Commensurate with the fluorescent spots being lysosomes and the more diffused fluorescence being Zn in a different subcellular location, Lysotracker signal intensity was increased at higher passage numbers (Fig. 4 , Panels a, b and c) but its colocalization with Fluozin-3 decreased in the L-HCAEC compared with nL-HCAEC sub-population and at later compared with earlier passages of the L-HCAEC sub-population (Fig. 4 , Panels d-h).
Expression of Zn regulating genes in HCAECs and HUVECs at earlier and later passages revealed by analysis of transcriptomic data
To gain further insight into the relationship between Zn homeostasis and endothelial cell senescence we compared transcriptomes at early and late passages in two different endothelial cell lines (HCAEC and HUVEC) to determine commonalities and eliminate responses that are cell-line specific. Data from HCAECs were from our published work that compared passage 6 with passage 12 (GEO accession number GSE77239) (Costarelli et al., 2017) . Data from HUVECs were from were from a study that compared cells at passage 4 with cells at passage 18 (GEO accession number GSE13712) (Mun et al., 2009) . The workflow of this study is presented as Supplementary Fig. 3 . In HUVECs, 7469 probesets were expressed differently (3227 up-and 4209 downregulated) in the earlier compared with the later passage while in HCAECs 11,897 probesets were expressed differently (5180 up-and 6717 downregulated) in the earlier compared with the later passage. Merged analysis identified 4140 probesets (2008 up and 2132 downregulated) expressed differently in endothelial cells at earlier compared with later passages. Nine of these probesets (for a total of 5 genes -SLC30A1, SLC39A6, MTF1, SLC39A13, SLC39A7) were involved in Zn homeostasis and showed a similar response (direction of change) in HCAECs and HUVECs (Table 2 ). Other players in Zn homeostasis were differently expressed between the earlier and later passage in only one of the two endothelial cell lines (Suppl . Tables 2 and 3 ). Cluster analysis of these genes clearly discriminated endothelial cells at later versus earlier passages (Suppl. Fig. 4 ). All probesets tagged to genes known to regulate Zn homeostasis were also used for principal component analysis, which generated two functions, PCA1 and PCA2 (Suppl . Table 4) , that significantly discriminate cell type and early/late passage, respectively (Suppl. Fig. 5 ). PCA2 was positively correlated with probesets tagged to Zn exporters (SLC30A1), intracellular importers (SLC30A5, SLC30A6), Zn sensors (MTF1) and MT genes, thus suggesting a strict relationship with Zn mobilization. Correlation of PCA2 with genes selected from the transcriptome data that are known to regulate apoptosis in senescent cells (Suppl. Table 5 ) (Zhu et al., 2015) identified at least 4 genes associated with intracellular Zn mobilization (BCL2L1, SERPINE2, CDKN1A and ABL1). Other genes highly correlated with PCA2 (r > 0.865 and p < 0.001) and significantly affected by endothelial cell passage number (in total 117 genes) included several genes known to be involved with cell cycle arrest (CDKN2A, CDKN2C, CCNA1, CENPA, CDKN2C, FOXM1, NEK6) and cell adhesion (ICAM1, CLDN1, CECAM1, PLAUR) (Suppl. Table 6 ).
Expression of targeted Zn regulating genes during growth of control and Zn-treated HCAECs
We reasoned that the changes in labile Zn in HCAECs as CPDs increased would be manifest as an altered response of Zn-sensitive genes to Zn. Thus, we measured the response to Zn at different CPDs of a panel of genes identified primarily from the transcriptomic data. These included common genes significantly different in later compared with earlier passages of HCAECs and HUVECs (SLC30A1, SLC39A6), a subset of genes that characterized PCA2 (SLC30A5, SLC39A1, MT2A, MT1X, MT1F) and additional genes known to be modulated by Zn or by Zn regulated transcriptional factors (SLC30A10, SLC39A2, SLC39A3, CBWD, ZNF658). As we predicted, the response to Zn differed between cells grouped as early CPDs versus late CPDs for specific genes in this panel -ZnT10, MT2A and MT1F -as shown through a significant interaction between Zn and CPD revealed by statistical analysis (mixed models for repeated measures) (Fig. 5) .
When we included all gene expression data in a model of automatic regression versus p16 expression we identified the ratio between ZNF658 to SLC30A10 as the most important predictor (Suppl. Fig. 6 , Panel A).
Metallothionein protein expression
While MT mRNAs were found to be only slightly affected by senescence in the HCAEC model we investigated if protein expression followed a similar pattern. Protein expression of MTs was found to be downregulated in late CPDs of both treated and untreated cells (Suppl. Fig. 7 ).
Effect of acute treatment with increasing doses of Zn and TPEN in proliferating and senescent cells
The altered Zn homeostasis observed in endothelial cells at later passages led us to investigate if senescent HCAECs and/or HCAECs at later passages are more susceptible to death (measured by propidium iodide) induced by an acute treatment with increasing doses of Zn or of the Zn chelator TPEN. For this purpose, we used samples of cells with a viability higher than 75%. With this criterion, we excluded potential bias due to the occurrence of death processes in HCAEC after passage 10. Treatment with TPEN for 48 h in cells at an earlier passage (passage 5), decreased viability at concentrations of 100 and 500 nM in both nL-HCAEC and L-HCAEC sub-populations compared with untreated cells (Fig. 6, Panel A) . Treatment of cells at the earlier passage with Zn (as M. Malavolta et al. Experimental Gerontology 99 (2017) 35-45 ZnSO 4 ) induced a decrease in viability at concentrations of 100 and 150 μM exclusively in the L-HCAEC sub-population (Fig. 6, Panel B) . This observation indicates that the few HCAECs with high Zn staining and morphological features of senescent cells that are present in early passages (around 5% of the whole cell population, as displayed in Fig. 2 ) are more susceptible than proliferating cells to death induced by high Zn. Surprisingly, none of the TPEN doses induced significant evidence of cell death in either sub-population of cells at a higher passage number (passage 10; Fig. 6 , Panel C). This observation leads us to suggest that there are further sub-divisions of both L-HCAEC and nL-HCAEC sub-populations that are resistant to zinc depletion that increase in proportion at higher passage numbers. The response to Zn of cells at the higher passage number was the same as at the lower passage number; only the senescence-enriched L-HCAEC sub-population showed a significant loss of viability (Fig. 6, Panel D) . We interpret this pattern of response to Zn as revealing that replicating endothelial cells must first pass through the senescent state to be killed by excess Zn.
Discussion
We provide evidence that Zn promotes the entry of HCAECs into senescence, and that senescent HCAECs show disrupted Zn homeostasis, which may be related to the susceptibility of senescent cells to undergo cell death in response to Zn treatment. We also show that Zn depletion leads to death of only young, replicating cells.
Acceleration of entry into senescence by Zn was shown as accelerated growth arrest and through an observation that Zn increases the proportion of larger cells, detected using flow cytometry, that have features of senescent cells, including expression of the senescence markers SA-β-gal and p16. Labile Zn, measured using Fluozin-3, increased over the culture lifespan of HCAECs and was higher in the senescence-enriched, larger cell sub-population (L-HCAEC sub-population).
As expected, the lysosomal compartment, revealed by staining with Lysotracker dye, increased at later passages. However, the higher Zn content was not accommodated entirely within lysosomes, as revealed by reduced co-localization of Fluozin-3 and Lysotracker signals. Zn in the cytoplasm or other compartments may play a role in the synthesis of Zn dependent proteins of the senescence associated secretory phenotype (SASP) as well as in other aspects of the senescent cell phenotype (Pantsulaia et al., 2016) . Since intracellular labile Zn is an important element of the cellular stress response, cellular metabolic activity and synthesis of proteins (Beyersmann and Haase, 2001 ), the changes observed may reflect increased proteotoxic stress as a consequence of the SASP (Coppé et al., 2010; Dörr et al., 2013) . In senescent vascular smooth muscle cells, it has been reported that mitochondria are sites of accumulation of Zn and that this phenomenon is related to an increase in the production of reactive oxygen species (ROS) (Salazar et al., 2017) .
Altered Zn homeostasis was evident as changes in gene expression at later passages of HCAECs, as well as through these changes in Zn content and distribution. The players in Zn homeostasis that were found to be altered at later stages in the culture lifespan included genes that are responsive to Zn treatment and that normally act to protect cells against Zn toxicity. These included SLC30A1, SLC39A5, SLC30A6, SLC30A10 and MTs. Notably, SLC30A10 and SLC30A5 are both under the control of ZNF658 (Ogo et al., 2015) and the ZNF658 to SLC30A10 mRNA ratio was highly correlated with the mRNA of the senescence marker p16, suggesting that the component of the Zn-homeostatic machinery regulated by ZNF658 may be particularly pivotal in the transition between endothelial cell replication and senescence. In concordance with this proposal, the Zn transcriptional regulatory element (ZTRE), which mediates the effect of ZNF658 on gene transcription, was identified in at least 3 genes (HSPA9, RAD51 and NOS3) (Coneyworth et al., 2012) that are known to counteract cellular senescence (Rodier et al., 2011; Xiao-Hong et al., 2013; Yaguchi et al., 2007) . These findings concur with observations made in vascular smooth muscle cells, where cellular senescence was found to be mediated by downregulation of SLC30A10 (as well as SLC30A3) (Patrushev et al., 2012) . The data do not allow us to disentangle cause and effect with respect to which changes in expression of the Zn homeostatic machinery may drive cells into senescence and which are consequences of the ensuing Zn-dyshomeostasis. It is likely that these interactions are complex, and that several Zn-responsive genes, including Zn transporters, rather than a single 'trigger' gene, contribute to promoting senescence. Determining if overexpression or knockdown of individual Zn transporters in cells at later passages reverses the senescent phenotype would be informative in this context. Overall our results are consistent with an upregulation of Zn responsive genes in senescent endothelial cells with the notable exception of MT mRNAs in the HCAEC model, which were unaltered (MT1X and MT2A) or slightly reduced (MT1F) in the absence of Zn treatment. MT protein was also slightly reduced. The nature of this dichotomy is still not completely explained, but may be a consequence of increased oxidative stress in senescent endothelial cells (Donato et al., 2015) and the increased propensity for oxidized and apo-MTs that have released Zn in response to be degraded (Klaassen et al., 1994) . We have previously observed a similar phenomenon in late passages of T cell clones (Malavolta et al., 2008) . We observed that HCAECs at later passages nonetheless retained the capacity for Zn to induce MTs, specifically MT2A and MT1F.
On the basis of the perturbed Zn homeostatic response we observed in endothelial cells at later passages, we predicted that cells would be more susceptible to cell death induced by using TPEN to deplete Zn or to Zn excess at later passages. However, we found that cells at an earlier passage (passage 5) were more susceptible to death induced by TPEN than were cells at a later passage (passage 10), and that this observation applied to both the nL-HCAEC and L-HCAEC sub-populations. We interpret this observation as revealing that there are further sub-divisions of both sub-populations (shown schematically in Fig. 7 ) that are resistant to zinc depletion and that these increase in proportion at higher passage numbers. Resistance to death by apoptosis is a feature of senescent cells. Thus, these finding concur with this paradigm. The range of doses of TPEN applied were 20 to 500 times lower than the TPEN concentration (10 μM) that is used to completely deplete Zn from cells (Seve et al., 1999) . Hence, the level of Zn depletion achieved is likely to be commensurate with depleted levels that can be observed in human plasma. We posit that the (large) senescent sub-population of these persistent cells may contribute to the reported association between atherosclerosis and Zn deficiency (Chen et al., 2016; Tomat et al., 2011) and may increase disease risk under conditions of impaired Zn homeostasis and depleted plasma Zn concentration, for example in older age.
We observed no difference in the response to chronic exposure to high concentrations of Zn between cells at the earlier and later passage. Only the senescence-enriched L-HCAEC sub-population at both points in the replicative lifecycle showed a significant loss of viability. We interpret this pattern of response to show that replicating endothelial cells must first pass through the senescent state to be killed by excess Zn (shown schematically in Fig. 7) . In these experiments, we exceeded by 10 times the concentration in human plasma (around 15 μM). Concentrations of this order would not be achievable in the plasma because homeostatic mechanisms are invoked to maintain relatively stable plasma Zn levels. However, we did not aim to mimic conditions that may be achievable in vivo. Our aim was to apply a maximal challenge to the endothelial intracellular Zn homeostatic processes to probe the relationship between Zn and endothelial cell senescence and death. Our finding that senescence might precede cell death even under such an extreme Zn challenge makes this finding particularly robust. The Zn response function (PCA2) identified by principal component analysis of gene expression differences between early and later passages of endothelial cells was correlated with the expression of genes known to regulate apoptosis in senescent cells. Hence, it is likely that the addition of Zn may accelerate the activation of these pathways and contribute to the death observed in the senescence-enriched sub-population. This retained sensitivity to death induced by acute Zn toxicity is converse to the known resistance to apoptosis of senescent cells, but concurs with retained sensitivity to death induced by Zn we observed over chronic exposure to the lower (50 μM) dose and is supportive of our proposal that Zn dyshomeostasis in senescent cells would render them sensitive to death induced by Zn.
Conclusions
In conclusion, chronic exposure to a moderately high dose of Zn accelerates senescence in HCAECs. Senescent HCAECs display altered Zn homeostasis characterized by intracellular relocation of Zn, and endothelial cells at later passages show increased expression of several genes involved in protection against Zn toxicity. Only senescent HCAECs undergo cell death in response to short-term treatment with a high dose of Zn. Both replicating cells and cells with senescent-like morphology (L-HCAEC gate) are killed by Zn depletion at earlier passages, but senescent cells acquire resistance to Zn depletion at later passages, which may underline a potential vascular pathological mechanism related to the accumulation of harmful senescent endothelial cells under conditions of Zn deficiency or systemic Zn-dyshomeostasis. studentship to OAO).
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